BREAKING
Sanara MedTech Inc. (SMTI) Q4 Earnings: Misses on EPS, Revenue Recap 6 minutes ago LENZ Therapeutics, Inc. (LENZ) Reports Wider Q4 Loss Than Expected 9 minutes ago UTStarcom Holdings Corp. (UTSI) Reports Q2 Earnings 13 minutes ago LightInTheBox Holding Co., Ltd. (LITB) Q4 2025 Earnings Recap 24 minutes ago LightInTheBox Holding Co., Ltd. (LITB) Reports Q4 Earnings 27 minutes ago COMPASS Pathways plc (CMPS) Reports Q4 Earnings 37 minutes ago Core & Main, Inc. (CNM) Misses Q4 EPS Estimates by 32.3% 42 minutes ago Concentrix Corporation (CNXC) Misses Q1 EPS Estimates 47 minutes ago Sanara MedTech Inc. (SMTI) Misses Q4 EPS Estimates by 215.9% 53 minutes ago Achieve Life Sciences, Inc. (ACHV) Reports Wider Q4 Loss Than Expected 1 hour ago Sanara MedTech Inc. (SMTI) Q4 Earnings: Misses on EPS, Revenue Recap 6 minutes ago LENZ Therapeutics, Inc. (LENZ) Reports Wider Q4 Loss Than Expected 9 minutes ago UTStarcom Holdings Corp. (UTSI) Reports Q2 Earnings 13 minutes ago LightInTheBox Holding Co., Ltd. (LITB) Q4 2025 Earnings Recap 24 minutes ago LightInTheBox Holding Co., Ltd. (LITB) Reports Q4 Earnings 27 minutes ago COMPASS Pathways plc (CMPS) Reports Q4 Earnings 37 minutes ago Core & Main, Inc. (CNM) Misses Q4 EPS Estimates by 32.3% 42 minutes ago Concentrix Corporation (CNXC) Misses Q1 EPS Estimates 47 minutes ago Sanara MedTech Inc. (SMTI) Misses Q4 EPS Estimates by 215.9% 53 minutes ago Achieve Life Sciences, Inc. (ACHV) Reports Wider Q4 Loss Than Expected 1 hour ago
ADVERTISEMENT
Analysis

CannTrust may be cheap, but stay away from this pot stock

Shares of CannTrust Holdings (NYSE: CTST) have plunged over 80% in the past 12 months, making it quite cheap with respect to its cannabis growing potential. It might look like an irresistible offer at this price, for a marijuana stock that comes with immense growth potential. Yet, it’s safe to stay clear. If you have […]

September 13, 2019 2 min read
Analysis

Shares of CannTrust Holdings (NYSE: CTST) have plunged over 80% in the past 12 months, making it quite cheap with respect to its cannabis growing potential. It might look like an irresistible offer at this price, for a marijuana stock that comes with immense growth potential. Yet, it’s safe to stay clear. If you have […]

Shares of CannTrust Holdings (NYSE: CTST)
have plunged over 80% in the past 12 months, making it quite cheap with respect
to its cannabis growing potential. It might look like an irresistible offer at
this price, for a marijuana stock that comes with immense growth potential. Yet,
it’s safe to stay clear.

If you have not been following the stock, the logic wouldn’t strike you too quickly. The Ontario-based company has been embroiled in two major scandals recently, making it quite difficult to convince investors that it is a credible firm.

Canopy Growth Co-CEO Bruce Linton exits
Image by Rex Medlen from Pixabay

The first was in July when it was discovered that CannTrust illegally grew marijuana in rooms hidden behind walls, besides exporting some of this to countries such as Denmark. Worse, the management allegedly knew about these wrongdoings but remained silent about it.

CannTrust had fired its CEO Peter Aceto following the
incident.

Regulators are yet to announce a punishment, which could be anywhere between cutting down its inventory to scrapping its license. Though a takeover could put a gradual end to CannTrust’s woes, uncertainty surrounding the penalty faced by the company makes it an unattractive takeover target.  

READ: Aurora, Canopy Growth to be the biggest gainers in Cannabis 2.0

Even if a potential buyer comes forward, it will be tasked with the cumbersome job of convincing the regulators that its practices would change following the merger.

Amidst all this, CannTrust once again came under the hammer after the Ontario Cannabis Store returned about $3 million worth of its products for not conforming to the supplier agreement.  This double whammy almost wipes of CannTrust’s credibility and makes regaining investor confidence a major hurdle.

On a whole, pot stocks may not be performing as one might have expected. Yet, when so many credible firms are out in the market, it makes little sense to try CannTrust even at the given valuation.

Browse through our earnings calendar and get all scheduled earnings announcements, analyst/investor conference and much more!

ADVERTISEMENT